CLARITY (Clinical Implications of Azole Resistant Aspergillosis in Hematological Diseases A Multi National Study)
Coordinator Oliver Cornely (Germany)
Objectives:
Assessment of the
Efficacy of antifungal treatment in patients with IA
Clinical significance of azole resistance compared to azole susceptibility ininvasive aspergillosis
Inclusion criteria:
Hematologic underlying disease
Azole susceptible or azole resistant invasive aspergillosis caused by Aspergillus fumigatus Proven or probable EORTC/MSG criteria
Clinical isolate and/ or in vitro susceptibility to triazoles is determined